Canine Influenza Virus: Fact or Fiction? by unknown
The H1N1 virus has been making headlines 
for nearly a year, yet there is still much confu-
sion about the reality of the situation. Reports 
that use words like “outbreak” and “emerging 
disease” often incite fear and leave us gripped 
by overly active imaginations. Picturing im-
minent world collapse, we forget to take the 
time to study available information, separate 
fact from fiction, and follow a reasonable 
course of action. 
In the veterinary and sheltering worlds, 
there are parallels in the reaction to the spread 
of canine influenza virus (CIV), which was 
first identified and made headlines in 2004. 
Recently, CIV has been back in the spot-
light following conditional licensure and re-
lease of the first canine influenza vaccine. 
Many questions—How effective is the vac-
cine? Should we test our animals? How con-
cerned should we be?—have been circulating 
in the animal sheltering community. It seems 
an ideal time for those of us concerned about 
the health and welfare of dogs to refresh our-
selves with available information, determine 
a reasonable action plan related to canine in-
fluenza virus, and separate fact from fiction.
Fact: When dealing with “kennel 
cough” in a shelter dog or a whole 
population of dogs, CIV is one of 
many possible causes to consider.
Canine infectious respiratory disease com-
plex, or “kennel cough,” is a common syn-
drome—especially in shelter dogs. Most 
humane facilities that house populations of 
dogs manage cases of infectious cough on 
a daily basis. The primary agents associated 
with the kennel cough syndrome include bac-
terial and viral pathogens, such as Bordetella 
bronchiseptica, Mycoplasma species, canine 
distemper virus, canine parainfluenza virus, 
and canine adenovirus-2. Each of these 
agents can cause similar clinical signs, in-
cluding sudden onset of fever, loss of appe-
tite, cough, and nasal discharge. 
In early 2004, an influenza A virus was 
recovered from the lung tissue of a racing 
greyhound who had succumbed to severe 
respiratory disease in Florida. Analysis of 
the viral genome revealed that the isolate 
was closely related to an equine H3N8 in-
fluenza virus. Since 2004, thousands of CIV 
cases and confirmed outbreaks have been 
reported in more than 25 states and the 
District of Columbia, according to Cornell 
University’s Animal Health Diagnostic 
Center webpage (diaglab.vet.cornell.edu/is-
sues/civ-stat.asp). 
The total number of CIV cases that have 
occurred is not known. However, a recent 
one-year study, conducted by real-time 
polymerase chain reaction (PCR) testing at 
Colorado State University, found dogs shed-
ding the CIV virus in 11 out of 16 shelters (69 
percent) that were experiencing outbreaks of 
canine respiratory disease. 
CIV is clearly an important new differen-
tial diagnosis for any dog with acute respira-
tory disease. 
Fiction: Canine influenza is really 
only a problem in animal shelters.
Dogs of any age, breed, and health status are 
susceptible to canine influenza if they have 
not had previous exposure to the virus. Like 
influenza viruses that affect other species, 
CIV is easily transmitted in cough and sneeze 
droplets and can be transmitted through fo-
mites (hands, clothing, and other objects that 
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recovery may take several weeks. Rarely, 
severe to fatal disease may occur. Thus CIV 
is a disease that causes a high morbidity 
(many affected), but a relatively low mortality 
(death rate) when appropriately diagnosed 
and managed. 
Fiction: Outbreaks of CIV are easily  
recognized in a facility or population 
of dogs.
Much focus has been placed on outbreak 
recognition and management. When CIV first 
enters a group of susceptible dogs, a presump-
tive diagnosis may be made based on the 
rapid spread of an acute respiratory disease 
accompanied by fever that is unrelated to vac-
cine history and associated with a prolonged 
or complete lack of response to therapies that 
are generally effective for other causes of ca-
nine infectious respiratory disease. 
Laboratory diagnosis is still required to 
differentiate CIV from other causes of acute 
respiratory disease, but the rapid spread can 
be suggestive. However, when CIV enters fa-
cilities where kennel cough is already occur-
ring, it may not be immediately recognized as 
anything “new,” but instead may appear to be 
a gradual worsening of the existing problem. 
In these situations, failure to perform rapid 
and appropriate diagnostic testing—and to 
offer timely treatment specifically designed 
to treat the disease—can lead to decline in 
the welfare and health of the entire popu-
lation. Therefore, in a population of dogs 
showing an increase in the number of acute 
respiratory disease cases, overall severity of 
illness, or a prolonged to complete lack of 
response to usually effective therapies, CIV 
should be a consideration, and diagnostics 
should be pursued.
Fiction: CIV can be diagnosed 
based on clinical signs alone.
Laboratory diagnosis is required to distin-
guish canine influenza from other causes of 
acute respiratory disease. There are multiple 
diagnostic methods available for testing; each 
has strengths and weaknesses. 
“Too often, facilities test only one or two 
dogs using only one test method, and the di-
agnosis is missed,” says Gabriele Landolt, a 
virologist who is researching canine influenza 
in animal shelters through a Morris Animal 
Foundation grant. “To identify the causative 
CIV does not spontaneously erupt in fa-
cilities; initial cases have to enter from com-
munity sources to start the cycle of infection, 
reflecting a community problem. 
The virus does not survive long in the en-
vironment (it can remain viable on surfaces 
for 48 hours, on clothing for 24 hours, and on 
hands for 12 hours) and is easily killed with 
routine cleaning and disinfection, but many 
facilities do struggle to break the cycle of 
transmission once the virus is introduced. 
There is still much that remains to be stud-
ied about how this virus circulates, persists, 
and evolves in the dog population—both in 
owned and in homeless animals. 
Fiction: Dogs with CIV frequently 
die rapidly, with signs of 
hemorrhagic pneumonia. 
Initial reports indicated that canine influenza 
virus caused significant mortality in affected 
dogs. But it now appears that the disease be-
haves like influenza infections in many other 
species. Most dogs will recover without seri-
ous complications. 
Following infection, the virus replicates 
quickly in dogs’ respiratory tract cells. There is 
a two-to-five-day period during which nonspe-
cific clinical signs (such as fever and lethargy) 
occur. It is during this early incubation period 
that peak nasal viral shedding occurs. Around 
days five to seven, more visible clinical signs of 
cough and nasal discharge develop. Typically, 
viral shedding wanes by days seven to 10, but 
that can vary in individual dogs. 
It is important to note that by the time ob-
vious clinical signs develop, the period when 
animals are most infectious often has already 
passed. In many facilities where animals are 
isolated only after clinical signs are noticed, 
infection control becomes a significant chal-
lenge because viral shedding and transmis-
sion to other dogs has already occurred. The 
majority of affected dogs (80-90 percent) will 
show mild to no clinical signs, while a smaller 
percentage of dogs (10-20 percent) may de-
velop more severe illness characterized by 
high fever, lethargy, rapid breathing, and sec-
ondary bacterial bronchopneumonia. 
In uncomplicated cases, the respiratory 
tract may begin to heal in as little as three to 
five days following infection. In other cases, 
cell damage may predispose animals to ac-
quiring secondary bacterial infections, and 
can be contaminated with disease agents and 
act to spread the disease). 
That said, the risk of infection is lowest 
for pet dogs who have little exposure to other 
dogs or dog facilities, and greatest for dogs 
who are housed in group environments or 
have frequent contact with other dogs, such 
as through boarding kennels, day cares, dog 
parks, veterinary hospitals, and shelters. 
Laboratory diagnosis is required to 
distinguish canine influenza from other 
causes of acute respiratory disease. Here, a 
veterinarian acquires a nasal swab from a 
dog to submit for polymerase chain reaction 
(PCR) testing.
This photo was taken in a shelter where a 
high rate of canine infectious respiratory 
disease was affecting the dog population. 
Nearly every dog had been placed on 
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broad-spectrum therapy is recommended to 
cover most of the likely secondary pathogens. 
Cough suppressants are not recom-
mended for CIV dogs experiencing productive 
coughs. Some practitioners report anecdotal 
response to a single anti-inflammatory dose 
of glucocorticoids, but this is not documented 
well and not without risk. 
Antiviral medications specifically aimed 
at influenza infections are available, but not 
advocated for use with CIV for several rea-
sons. These drugs must be given very early 
in the infection for effect, there are no rec-
ommended dosing strategies, there are no 
efficacy or safety studies available in dogs, 
and the virus may develop resistance to these 
drugs. Furthermore, they are expensive med-
ications that—especially these days—are 
often being conserved for use in humans. 
In severe cases of secondary pneumonia, 
oxygen therapy, nebulization, and bronchodila-
tor therapy may be helpful.  However, such in-
tensive therapy can be difficult to provide on a 
large scale, and if dogs are severely affected and 
intensive care is not available, euthanasia may 
become necessary for herd welfare reasons.
dogs are recommended) who have entered 
the facility at various times and are exhibit-
ing different clinical signs. For more informa-
tion on testing methods, read the chapter 
on canine influenza in the newly available 
textbook, Infectious Disease Management in 
Animal Shelters.
Fiction: Doxycycline is a 
good standard antibiotic 
for all dogs with CIV.
Not all dogs affected by CIV will require ther-
apeutic intervention. When medication does 
become necessary, there is no single correct 
treatment. For many CIV cases, supportive 
care may be all that is required. Good nutri-
tion, maintenance of hydration, and minimi-
zation of stress are still critical components of 
therapy even when medication is in use. 
Dogs who show signs of secondary bacte-
rial infections (e.g. mucoid nasal discharge, 
productive cough, or pneumonia) should 
be treated with broad-spectrum antibiotics. 
Ideally, antibiotics should be chosen on the 
basis of culture and sensitivity. Until culture 
and sensitivity results become available, 
agent accurately and rapidly, thus allowing 
to institute optimal control measures, it may 
be necessary to combine several diagnostic 
tests and test multiple dogs in varying stages 
of disease.” 
The timing of sample collection relative to 
when an animal was infected relates directly 
to test performance. Some tests, like PCR 
analysis and other methods aimed at detect-
ing the virus, are designed to work during the 
first few days following infection, when dogs 
are shedding infectious virus but showing few 
clinical signs. These tests are preferred for an 
early clinical infection. 
Other tests, like serology (blood tests), 
measure exposure to the virus through an-
tibody levels, which do not develop until at 
least seven days following infection (or po-
tentially, following vaccination). A compari-
son of serum samples taken two weeks apart 
is recommended to document recent expo-
sure through a fourfold increase in the levels 
of antibodies. 
In a population of dogs, the odds of cap-
turing a positive sample increase by collect-
ing samples from multiple animals (five to 10 
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shelters that house dogs long term may bene-
fit more than those with short turnover times. 
The only available efficacy studies by the 
vaccine company demonstrate that use of the 
product lessens clinical signs of disease and 
decreases—but does not eliminate—virus 
shedding. Influenza vaccines used in many 
species have similar effects; vaccinated dogs 
can still become infected and shed virus, but 
may not become as clinically affected and 
may not infect other dogs as readily. This vac-
cine has been termed a “lifestyle vaccine,” 
much like available vaccines for Bordetella 
bronchiseptica. The best use of the vaccine 
appears to be for preemptive vaccination of 
dogs at high risk of exposure to CIV. 
The Last Word
Much like the present situation with H1N1, 
canine influenza virus—although a serious 
issue for shelters—is certainly not grounds 
for panic. The recent identification of H1N1 
in a cat, and apparent transmission of H1N1 
from humans to other animals, serves as a 
reminder that influenza viruses are notori-
ously unpredictable and require vigilant 
monitoring. 
Cats do not appear to present a significant 
risk for viral transmission of H1N1, and the ca-
nine influenza H3N8 virus seems to transmit 
primarily dog-to-dog with minimal zoonotic 
risk, but much remains unknown about both 
of these viruses. Thus far, there is no way to 
prevent CIV, but it is possible for shelters to 
limit the consequences of widespread disease 
and contribute to an improved understanding 
of how the virus transmits, persists, and can 
be prevented through standard infection-con-
trol measures, diagnostic testing, separation 
of affected animals, appropriate therapy, and 
proactive community education. 
Miranda Spindel is the director of veterinary 
outreach at the ASPCA and past president of 
the Association of Shelter Veterinarians. She 
initiated and completed the first residency in 
shelter medicine offered though Colorado 
State Universit y and founded the CSU 
student chapter of the Association of Shelter 
Veterinarians.
exposed dogs, but if this is not possible, staff 
should care for the unexposed dogs first. 
Measures that reduce fomite transmission 
should be in place, including frequent hand 
washing, use of personal protective equip-
ment like disposable gloves, cover-up gowns 
and boots, and protocols that encourage fol-
lowing “all-in, all-out” procedures (meaning 
that a staffer should enter with all necessary 
supplies, perform their tasks in the area, and 
then exit, rather than going back and forth 
into the area and increasing the chances of 
contamination). 
Though its effectiveness is controversial, 
the use of regularly changed footbaths or dis-
infectant mats outside of quarantined areas 
is unlikely to do harm and may serve as a re-
minder to staff of other necessary biosecurity 
measures. 
Fiction: The H3N8 Vaccine is 
considered a core shelter vaccine.
When weighing whether the new H3N8 CIV 
vaccine will benefit shelters, there are a num-
ber of things to consider. 
Vaccines are an important part of influ-
enza control in all species, and the develop-
ment and conditional approval of a vaccine 
for canine influenza is an important step to-
ward better management of canine influenza 
virus. But before shelters put a new product 
into widespread use, they should consider 
information about the product, how it works, 
and the potential risks and benefits. 
It is also important to recognize that 
whenever a new vaccine is conditionally re-
leased, there are often many factors yet to be 
researched. “Some of the currently unknown 
aspects of the H3N8 vaccine include the max-
imum duration of immunity induced by the 
vaccine, whether there is benefit in vaccinat-
ing around the time of exposure, and whether 
evolution of field strains of the canine influ-
enza virus might make the vaccine ineffective 
over time,” says Melissa Kennedy, a clinical vi-
rologist at the University of Tennessee College 
of Veterinary Medicine. 
Shelters also must consider that the vac-
cine is an inactivated product. It is labeled 
to be given as two doses spread two to three 
weeks apart to healthy dogs 6 weeks or older. 
This means that it can take weeks for a dog 
to respond maximally to the vaccine, and so 
Fact: A facility can break the 
cycle of transmission. 
Ultimately, widespread or uncontrolled re-
spiratory disease can affect an entire com-
munity. When CIV is confirmed in a facility, 
management decisions must be made to limit 
its impact, but CIV is difficult to control in 
most populations of dogs for several reasons. 
The virus spreads rapidly through the dog 
population, in part through sneeze droplets 
that can be difficult to contain. While some 
infectious dogs may show obvious clinical 
signs, others are asymptomatic, yet shedding 
infectious agent.
Because of the ease of transmission, an 
entire facility—not just the animals with clini-
cal signs—is considered exposed at the time 
of diagnosis. Ideally, dogs with clinical signs 
should be isolated away from exposed dogs, 
who are placed in a CIV quarantine area to 
watch for development of symptoms—but this 
is not always practical with a CIV quarantine. 
In order to break the cycle of infection, 
the exposed dog population needs to be con-
tained (no new dogs in and no dogs out) for 
the duration of viral shedding. A 14-day quar-
antine is recommended. Many dogs will re-
main symptomatic well beyond the time they 
are no longer shedding virus. 
Shelters and other facilities can achieve 
a quarantine in several ways. The simplest 
way to end a CIV outbreak is to stop admit-
ting any new dogs for a two-week period. 
However, this may not be a possibility for all 
facilities, and where it isn’t, new dogs can 
be separated from exposed dogs by using a 
temporary offsite facility (for either popula-
tion) for two weeks. In small programs, foster 
homes and rescue groups can be used during 
the period. 
Finally, some shelters have successfully 
continued to admit new dogs by strictly sepa-
rating new intakes from the exposed dogs. 
This may mean that the exposed dogs must 
be moved and/or grouped in a physical area 
of the building distant from where new dogs 
enter. Ideally, the two areas should have sepa-
rate ventilation systems, but at minimum there 
should be physical barriers (such as closed 
doors) to lessen aerosol transmission. 
As with any infectious disease, biosecurity 
measures are important. Suggestions include 
designating specific staff to care for the un-
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